Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease.
McConoughey SJ, Basso M, Niatsetskaya ZV, Sleiman SF, Smirnova NA, Langley BC, Mahishi L, Cooper AJ, Antonyak MA, Cerione RA, Li B, Starkov A, Chaturvedi RK, Beal MF, Coppola G, Geschwind DH, Ryu H, Xia L, Iismaa SE, Pallos J, Pasternack R, Hils M, Fan J, Raymond LA, Marsh JL, Thompson LM, Ratan RR.
McConoughey SJ, et al. Among authors: ratan rr.
EMBO Mol Med. 2010 Sep;2(9):349-70. doi: 10.1002/emmm.201000084.
EMBO Mol Med. 2010.
PMID: 20665636
Free PMC article.